Renal biopsy in the clinical management of patients
Keywords:
BIOPSY, KIDNEY DISEASES, HEMODIALYSISAbstract
Introduction: percutaneous technique of renal biopsy in clinical practice represents an irreplaceable method of study for renal diseases, which has contributed to its anatomical and clinical classification, deepening in the mechanisms of its etiology and pathogenesis, as well as to the scientific analysis of the therapeutic protocols. It provides diagnostic information, prognosis and, sometimes, the effectiveness of the treatment.
Clinical case: a 55-year-old mixed-race female patient with a history of hypertension, diabetes mellitus type 2, both controlled with diet for five years, and with a history of thrombophlebitis in the left lower limb, for which the patient was treated with multiple antimicrobials, resolving this condition one week after the last treatment, she attended the service due to nausea, shortness of breath, increased volume in both lower limbs and urine, missing the results.
Conclusions: the presentation of the case highlights the importance of percutaneous renal biopsy in the diagnostic and therapeutic management of patients with kidney disease. The patient had a marked improvement in renal function and of her quality of life; in addition, it contributed to a saving of material resources used in the renal replacement therapy (hemodialysis), since the patient had a regression of her chronic kidney disease, not continuing in the hemodialysis schedule.
Downloads
References
1. D'Agati VD, Mengel M: The rise of renal pathology in nephrology: structure illuminates function. AJKD[internet] 2013[citado 2017 nov 02]; 61(6):[aprox. 9p.]Disponible en :. https://www.ncbi.nlm.nih.gov/pubmed/23410654
2. Kitterer D, Gurzing K, Segerer S, Alscher MD, Amann K, Braun N, et al: Diagnostic impact of percutaneous renal biopsy. Clin Nephrol[intenet] 2015 Dec[citado 2017 nov 02] 84(6):[aprox.11].Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/26396098
3. Fiorentino M, Bolignano D, Tesar V, Pisano A, Van Biesen W, D'Arrigo G, et al. Group E-EIW: Renal Biopsy in 2015 - From Epidemiology to Evidence-Based Indications. Am J Nephrol [internet] 2016 [citado 2017 nov 02]; 43(1):[aprox.18].Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/26844777
4. Dhaun N, Bellamy CO, Cattran DC, Kluth DC: Utility of renal biopsy in the clinical management of renal disease. Kidney Int [internet] 2014 May[citado 2017 nov 02];85(5):[aprox.9p.].Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/24402095
5. Whittier WL, Korbet SM (eds.): Indications for and complications of renal biopsy. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA ; 2016. Disponible en :http://www.uptodate.com/contents/indications-for-and-complications-of-renal-biopsy
6. Vázquez Martul E: Orientación diagnóstica de las enfermedades renales glomerulares. Revista Española de Patología [ìnternet] 2013 [citado 2017 nov 02]; 46(1):[aprox.10p.].Disponible en : http://www.elsevier.es/es-revista-revista-espanola-patologia-297-articulo-orientacion-diagnostica-las-enfermedades-renales-S1699885512000906
7. Wagrowska-Danilewicz M, Danilewicz M: Spectrum of biopsy-proven renal diseases in patients with type 2 diabetes mellitus. A single center study. Pol J Pathol. [internet] 2015 Dec[citado 2017 nov 02];66(4):[aprox.24p.].Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/?term=official+journal+of+the+Polish+Society+of+Pathologists+2015%2C+66%284%29%3A361-367
8. Ecotière L, Thierry A, Debiais-Delpech C, Chevret S, Javaugue V, Desport E, et al: Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients. NDT [internet] 2016 Jan[citado 2017 nov 02]; 31(1):[aprox.8p.].Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/?term=NDT+2016%2C+31%281%29%3A64-72.
9. McMahon GM, McGovern ME, Bijol V, Benson CB, Foley R, Munkley K,: Development of an Outpatient Native Kidney Biopsy Service in Low-Risk Patients: A Multidisciplinary Approach. Am J Nephrol [internet]2012[citado 2017 nov 02]; 35(4):[aprox.5p.].DIsponible en : https://www.ncbi.nlm.nih.gov/pubmed/?term=2012%2C+35%284%29%3A321-326
10. Miglinas M. Utility of renal biopsy in the clinical management of renal disease: hematuria should not be missed. Kidney Int [internet]2014 Dec[citado 20147 nov 02]; 86(6):1269.Disponible en : https://www.ncbi.nlm.nih.gov/pubmed/25427087
11. Haladyj E, Cervera R: Do we still need renal biopsy in lupus nephritis? Reumatologia [internet]2016[citado 2017 nov 02]; 54(2):[aprox.5p.].Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Reumatologia+2016%2C+54%282%29%3A61-66
12. Poulton CJ, Nachman PH, Hu Y, McGregor JG, Jennette JC, Falk RJ, et al. Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis. Clin Exp Rheumatol [internet] 2013 Jan-Feb [citado 2017 nov 02]; 31(1 Suppl 75):[aprox.5p.]Disponible en :. https://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Exp+Rheumatol+2013%2C+31%281+Suppl+75%29%3AS32-S37
13. Pagni F, Galimberti S, Goffredo P, Basciu M, Malachina S, Pilla D, et al. The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients. NDT[internet] 2013 Dec[citado 2017 nov 02]; 28(12):[Aprox.9p.]Disponible en :. https://www.ncbi.nlm.nih.gov/pubmed/?term=NDT+2013%2C+28%2812%29%3A3014-3023.
14. Bandari J, Fuller TW, Turner II RM, D'Agostino LA: Renal biopsy for medical renal disease: indications and contraindications. The Canadian journal of urology [internet]2016[citado 2017 nov 02]
;23(1):[aprox.5p.]DIsponible en:https://www.ncbi.nlm.nih.gov/pubmed/?term=The+Canadian+journal+of+urology+2016%2C+23%281%29%3A8121-8126.

Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/